Exemestane in Post-Menopausal Women With NSCLC

NCT02666105 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG: Exemestane

Sponsor

Masonic Cancer Center, University of Minnesota